Accolade, Inc. (ACCD) Stock
ACCD is no longer traded. Accolade was delisted from the Nasdaq in April 2025.
Prices on this page are historical; the last trade was April 7, 2025 at $7.02.
Accolade stock price history
ACCD final trading statistics
- Final close
- $7.02
- Final trading day
- Apr 7, 2025
- Market cap at delisting
- $575.59M
- Shares outstanding
- 81.99M
- Final 52-week range
- $3.08 – $9.67
- Avg. volume (final 3 mo.)
- 2,113,600
- All-time high (split-adj.)
- $59.72 · Dec 2020
- All-time low (split-adj.)
- $3.15 · Nov 2024
- Return since IPO
- -76.6%
- Beta
- 2.10
- Book value / share
- $3.85
- Price / book
- 1.82
Accolade annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $414.29M | -$99.8M | -$1.33 |
| FY2023 | $363.14M | -$459.6M | -$2.26 |
| FY2022 | $310.02M | -$123.1M | -$1.83 |
| FY2021 | $170.36M | -$50.7M | -$2.87 |
| FY2020 | $132.51M | -$51.4M | -$0.88 |
Last five fiscal years reported before the delisting; fiscal year ending February. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Accolade, Inc.
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.
Accolade stock FAQ
What happened to Accolade stock?
Accolade stock was delisted from the Nasdaq. Its final close was $7.02 on April 7, 2025.
Is ACCD stock still trading?
No. ACCD was delisted from the Nasdaq in April 2025 and no longer trades on a U.S. exchange.
What was the last price of ACCD stock?
ACCD closed at $7.02 on its final trading day, April 7, 2025, for a market value of about $575.59M.
What were Accolade's revenue and earnings in its last full fiscal year?
Accolade reported revenue of $414.29M and net income of -$99.8M in fiscal 2024, its last full year as a public company.
When did Accolade go public?
Accolade, Inc. stock began trading on July 2, 2020.